Review article: prognosis of hepatorenal syndrome--has it changed with current practice? - Wikidata - wikimedia - TriplyDB

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

http://www.wikidata.org/entity/Q35873832

about

Hepatorenal syndrome: Update on diagnosis and treatment Renal dysfunction in patients with cirrhosis: Where do we stand?The course of type 1 hepato-renal syndrome post liver transplantation.Transjugular intrahepatic portosystemic shunt.Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.Optimal management of hepatorenal syndrome in patients with cirrhosis.Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.

P2860

Q26777608-B772EA5D-7C48-45A9-A72F-A014EC58CCB8 Q34047665-EDECCC5A-7325-4BFD-A8CF-B29DE46C8E85 Q35160366-0B6635AA-FDFB-42C5-BA9E-F50B4C601AD7 Q36141446-178BC0FD-8F07-4A32-8483-9ED4C5822002 Q38002958-49A7084C-3C28-4885-8E1B-62DC00FB93A4 Q38173738-6024A1C3-CB2C-43EB-8014-BB573BE4E9DC Q46879588-9E97DAC2-99B5-4897-9CAF-545FDE79BA77

P2860

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

http://www.wikidata.org/entity/Q35873832

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@ast

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@en

type

label

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@ast

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@en

prefLabel

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@ast

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@en

P1433

Q35873832-259A45BE-572B-4382-8CD8-567C23357BA2

P1476

Q35873832-221EC6F2-9CF3-41BA-ADC1-5AE8748FED4A

P2093

Q35873832-1F5AF9C7-9BA5-4D66-A621-8229A51B290E

P2860

Q35873832-046DDB05-B77B-4117-B8D5-F13B79259FE2

Q35873832-1F6D19F0-1282-42B1-9C56-EA2A9D3C8C91

Q35873832-883DBBA4-AE8B-4475-8DDC-FD01C1401E9E

Q35873832-8A9AF8F9-7E01-448C-A1E7-9B50104B7E7B

Q35873832-8BE9C830-2E4A-46D3-BF6E-CA5AF4E81229

Q35873832-9D60FA3C-87A7-4E42-BD0C-747E523A1E6F

Q35873832-BA749F01-7572-4B1A-A5FE-F23C7F81F3C9

Q35873832-BAF3EB35-7E0E-4AC8-92D1-740F994C67EB

Q35873832-DDE3C8CA-4FF8-40BA-8EF0-4405C004ACB0

Q35873832-E9704A2D-2270-421B-A674-A9F89AFCF912

P304

Q35873832-3ACA22A3-7507-49EB-8345-8FEFEFBB846D

P31

Q35873832-004A88E7-C332-4A2F-B6B0-7E9C4D6ADA88

P356

Q35873832-6D7A012B-159C-48CE-BE0D-36DF26415A6E

P407

Q35873832-8E4EB120-D43E-4F87-82FD-4774BCF671F6

P478

Q35873832-7A8937D4-EBF3-4C47-8E8F-5D1804E5D24F

P577

Q35873832-AB5F4ACA-8468-43D7-833E-09444ACDFAD2

P5875

Q35873832-79A13C6D-F17E-4EB2-A5A6-E744EE2BEA28

P698

Q35873832-DEC28F50-A6CB-44D3-84CA-536329FA328B

P356

J.1365-2036.2004.02113.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

@en

P2093

Angeli P

http://www.w3.org/2001/XMLSchema#string

P2860

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis.

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study.

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.

P304

44-6; discussion 47-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2004.02113.X

http://www.w3.org/2001/XMLSchema#string

P407

P478

20 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8377797

http://www.w3.org/2001/XMLSchema#string

P698

15335400

http://www.w3.org/2001/XMLSchema#string